首页> 外文期刊>Medical Journal Armed Forces India >Bronchial artery embolization in treatment of hemoptysis: Treatment efficacy and complications at a tertiary care chest centre
【24h】

Bronchial artery embolization in treatment of hemoptysis: Treatment efficacy and complications at a tertiary care chest centre

机译:治疗咯血的支气管动脉栓塞:第三级护理中心的治疗疗效和并发症

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Background: Hemoptysis is one of the most alarming condition to both the patients suffering from it and the treating physicians. It is caused due to varied etiologies. One of the emergent and at times life-saving treatment option is by minimally invasive interventional radiological technique of Bronchial Atery Embolization (BAE). The authors aimed to carry out a retrospective analysis of short term efficacy and safety of all patients treated by this technique at a tertiary care thoracic centre.Methods: A total of 52 patients were included in the study who had a median follow up of 35 days. All these patients were referred for hemoptysis, intractable hemoptysis not controlled by conservative management or massive hemoptysis. An analysis of the underlying etiology, immediate and short term outcomes and complications was made. Results: The study showed Tuberculosis and its sequel (bronchiectasis and chronic fibrotic changes) as the commonest etiology (65%). The BAE showed high short term efficacy (92%) in stopping the hemoptysis with a relatively low complication rate especially of major complications such as spinal cord ischemia (1.9%). The study strengthens the limited Indian data available on the subject and based on its outcome, BAE should be tried in all patients presenting with uncontrollable or massive hemoptysis not getting relief by conservative management alone.Conclusion: BAE is a very effective procedure with very less complications for management of massive or uncontrollable hemoptysis.
机译:背景:咯血是患有它和​​治疗医师的患者最具惊人的状态之一。它是由于各种病因引起的。一系列紧急和有时拯救救生处理选项是通过微创介入介入的支气管疗中栓塞(BAE)。作者旨在对第三节护理胸部Centre治疗这种技术治疗的所有患者的短期疗效和安全性进行回顾性分析。方法:共有52名患者均纳入35天的中位后的中位。所有这些患者都被称为咯血,顽固的咯血,不受保守管理或大规模血液瘤的控制。对潜在病因,即时和短期结果和并发症进行了分析。结果:该研究显示结核病及其续集(支气管扩张和慢性纤维化变化)作为最常见的病因(65%)。 BAE在止动血液衰竭时显示出高的短期疗效(92%),特别是具有相对低的并发症率,特别是脊髓缺血等主要并发症(1.9%)。该研究加强了该主题上可用的有限的印度数据,并根据其结果,贝尤应在所有患者中均采用无法控制或巨大的咯血,而不是单独通过保守管理缓解。结论:BAE是一个非常有效的手术,并发症非常较少用于巨大或无法控制的咯血的管理。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号